Clincosm LogoSign in Get a demo

crc

Showing 1 - 25 of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Colorectal Cancer, CRC, Behavior Trial in Richmond (mHealth Application)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • mHealth Application
  • Richmond, Virginia
    Virginia Commonwealth University
Aug 4, 2023

Colorectal Cancer, CRC Trial in Miami (Fecal Immunochemical Test, Septin9 Test)

Completed
  • Colorectal Cancer
  • CRC
  • Fecal Immunochemical Test
  • Septin9 Test
  • Miami, Florida
    University of Miami
Jul 27, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

Solid Tumors, Melanoma, NSCLC Trial in France, Spain, United States (CFT1946, Trametinib)

Recruiting
  • Solid Tumors
  • +4 more
  • Boston, Massachusetts
  • +9 more
Dec 19, 2022

Microbiome in Colorectal Cancer Onset and Progression

Terminated
  • Colorectal Cancer
  • +4 more
    • Bellevue, Washington
      Washington Gastroenterology
    Dec 23, 2022

    Advanced or Metastatic Solid Tumors, Lung Cancer, Breast Cancer Trial in United States (NC318)

    Active, not recruiting
    • Advanced or Metastatic Solid Tumors
    • +8 more
    • Los Angeles, California
    • +5 more
    Nov 29, 2022

    Advanced Solid Tumors, NSCLC, Triple-negative Breast Cancer Trial in Barcelona, Madrid (OMO-103)

    Active, not recruiting
    • Advanced Solid Tumors
    • +3 more
    • OMO-103
    • Barcelona, Spain
    • +2 more
    Sep 27, 2022

    Solid Tumors, NSCLC, CRC Trial in United States (Telaglenestat (CB-839), Palbociclib Oral Capsule or Tablet [Ibrance])

    Completed
    • Solid Tumors
    • +3 more
    • Telaglenestat (CB-839)
    • Palbociclib Oral Capsule or Tablet [Ibrance]
    • Santa Monica, California
    • +9 more
    Sep 14, 2022

    Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)

    Recruiting
    • Oncology
    • +16 more
    • E-602
    • Pembrolizumab
    • Grand Rapids, Michigan
    • +4 more
    May 27, 2022

    CRC, Solid Tumor Trial in Beijing (KD-025)

    Recruiting
    • CRC
    • Solid Tumor
    • KD-025
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    May 16, 2022

    Novel Multitarget FIT in CRC Screening

    Enrolling by invitation
    • CRC
    • Advanced Neoplasia
    • Comparison of two tests (FIT and mtFIT) in the same bowel movement
    • Amsterdam, Netherlands
      Netherlands Cancer Institute
    May 13, 2022

    CRC Trial (HLX07, HLX10, mFOLFOX6)

    Not yet recruiting
    • CRC
    • (no location specified)
    May 1, 2022

    Solid Tumor, Adult, NSCLC, CRC Trial in Worldwide (D-1553, Other)

    Recruiting
    • Solid Tumor, Adult
    • +2 more
    • Fresno, California
    • +25 more
    Mar 28, 2022

    Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

    Terminated
    Has Results
    • Solid Tumor
    • +6 more
    • Birmingham, Alabama
    • +8 more
    Feb 16, 2022

    CRC Trial in Beijing (HL-085, Vemurafenib)

    Not yet recruiting
    • CRC
    • Beijing, Beijing, China
      Beijing Oncology Hospital
    Feb 6, 2022

    Liposarcoma, CRC, Prostate Cancer Trial in United States (PF-07220060, Letrozole, Fulvestrant)

    Recruiting
    • Liposarcoma
    • +5 more
    • New Haven, Connecticut
    • +8 more
    Jan 20, 2022

    CRC Trial in Shanghai (HLX208, Cetuximab Injection [Erbitux])

    Recruiting
    • CRC
    • HLX208
    • Cetuximab Injection [Erbitux]
    • Shanghai, China
      Fudan University Affiliated Oncology Hospital
    Dec 30, 2021

    Colorectal Cancer, Colorectal Carcinoma, Metastatic Cancer Trial in Orange (Cabozantinib, TAS-102)

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Sep 30, 2021

    Advanced Solid Tumor, NSCLC, CRC Trial in United States (JAB-21822 (KRAS G12C inhibitor), Cetuximab (EGFR inhibitor))

    Recruiting
    • Advanced Solid Tumor
    • +2 more
    • JAB-21822 (KRAS G12C inhibitor)
    • Cetuximab (EGFR inhibitor)
    • Phoenix, Arizona
    • +3 more
    Sep 7, 2021

    NSCLC, CRC, Solid Tumor Trial in Beijing (JAB-21822)

    Recruiting
    • NSCLC
    • +2 more
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Aug 11, 2021

    Donation of Post Mortem Tumor Tissues

    Recruiting
    • NSCLC Stage IV
    • +2 more
    • Proteomic analysis
    • Milano, Italy
      ASST GOM Niguarda
    Aug 16, 2021

    CRC Trial in Hong Kong (WhatsApp message, Telephone call)

    Withdrawn
    • CRC
    • WhatsApp message
    • Telephone call
    • Hong Kong, Hong Kong
      Prince of Wales Hospital
    Aug 2, 2021

    CRC Trial in Tel Hashomer (Pure-Vu System)

    Terminated
    • CRC
    • Pure-Vu System
    • Tel Hashomer, Israel
      Chaim Sheba Medical Center
    Feb 23, 2021